![Michael Wootton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Wootton
Vorstandsvorsitzender bei NF2 Therapeutics, Inc.
Profil
Michael Wootton is the President and Director of NFlection Therapeutics, Inc. which he founded in 2014.
Mr. Wootton is also the founder of NF2 Therapeutics, Inc.
Aktive Positionen von Michael Wootton
Unternehmen | Position | Beginn |
---|---|---|
NF2 Therapeutics, Inc.
![]() NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Michael Wootton
Unternehmen | Position | Ende |
---|---|---|
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Health Technology |
NF2 Therapeutics, Inc.
![]() NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Commercial Services |